Imaging Biometrics Ltd (IBAI) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Nov 2025 02:50 PM
RNS
Release of Next-Generation IB Clinic
24 Nov 2025 09:56 AM
RNS
Board Changes
13 Nov 2025 11:24 AM
RNS
Fractional Tumor Burden Mapping Enhances GBM Trial
10 Nov 2025 03:14 PM
RNS
IB Announces Completion of Phase 1 Trial of GaM
16 Oct 2025 07:00 AM
RNS
Further Re: Purchase of interest in Kirkstall Ltd
14 Oct 2025 12:15 PM
RNS
Purchase of Kirkstall and CLN - Correction
14 Oct 2025 07:00 AM
RNS
Purchase of Kirkstall and CLN with Truetide plc
03 Oct 2025 12:16 PM
RNS
Vivan Therapeutics and IB Announce Partnership
16 Sep 2025 03:49 PM
RNS
IB Enters Agreement with MedImageMetric
13 Aug 2025 11:48 AM
RNS
Half-year Report
07 Aug 2025 11:22 AM
RNS
Grant of Share Options
21 Jul 2025 07:00 AM
RNS
IB Announces Soft Close to Phase 1 Trial
09 Jul 2025 05:14 PM
RNS
Director/PDMR Dealing
12 Jun 2025 10:30 AM
RNS
IB Provides Update on BTD Application
27 May 2025 07:00 AM
RNS
Change of Name
22 May 2025 02:23 PM
RNS
Result of AGM
02 May 2025 07:29 AM
RNS
Application: FDA Breakthrough Therapy Designation
29 Apr 2025 10:49 AM
RNS
Notice of AGM
25 Apr 2025 01:46 PM
RNS
Publication of Annual Report
11 Apr 2025 03:32 PM
RNS
Promising Preliminary Results of Phase 1 Study
18 Mar 2025 10:38 AM
RNS
Placing to raise £250,000
03 Feb 2025 07:00 AM
RNS
IB Expands Distribution with Blackford
22 Jan 2025 07:00 AM
RNS
Operations Update
10 Jan 2025 07:49 AM
RNS
IB and Prism Secure First Installation
20 Nov 2024 07:00 AM
RNS
Imaging Biometrics Expands Distribution
19 Nov 2024 11:27 AM
RNS
Board Changes
05 Nov 2024 07:00 AM
RNS
New Patent Application and Trading Update
15 Oct 2024 10:28 AM
RNS
Holding(s) in Company
15 Oct 2024 07:00 AM
RNS
IQ-AI Issues Letter to Shareholders
14 Oct 2024 12:08 PM
RNS
Holding(s) in Company
14 Oct 2024 12:05 PM
RNS
PDMR dealing and TR1 announcement
11 Oct 2024 10:42 AM
RNS
Acquisition of Interest by Braveheart
13 Aug 2024 02:53 PM
RNS
Half-year Report
25 Jun 2024 09:59 AM
RNS
IB Opens Expanded Access Program
14 Jun 2024 08:38 AM
RNS
Clinical Trial Updates
29 May 2024 03:08 PM
RNS
Result of AGM
23 May 2024 07:00 AM
RNS
Major East Coast Health System Chooses IB Nimble
20 May 2024 07:10 AM
RNS
Second FDA Rare Pediatric Disease Designation
17 May 2024 07:00 AM
RNS
IB Software Enhances Clinical Decision-Making
10 May 2024 08:15 AM
RNS
Rare Pediatric Disease Designation Granted to GaM
02 May 2024 12:47 PM
RNS
IB Announces Expanded Access Program for GaM
29 Apr 2024 03:26 PM
RNS
Publication of Annual Report
05 Mar 2024 07:00 AM
RNS
Grant of Options
01 Mar 2024 08:22 AM
RNS
Holding(s) in Company
01 Mar 2024 08:20 AM
RNS
Holding(s) in Company
26 Feb 2024 07:00 AM
RNS
Result of Broker Option and Total Voting Rights
22 Feb 2024 07:00 AM
RNS
Placing and Broker Option
09 Feb 2024 12:49 PM
RNS
FDA Application Update
02 Feb 2024 08:39 AM
RNS
IB awarded a $100,000 grant
02 Feb 2024 08:39 AM
RNS
IB awarded a $100,000 grant

IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.

IQ-AI share price listed in London at 87p in 1996.

UK 100

Latest directors dealings